To explore the possible mechanisms by which M2 macrophages induce sorafenib resistance, we investigated the expression and phosphorylation of key components in HGF/c-Met, ERK/MAPK, and PI3K/AKT pathways in tumour cells of SMMC-7721 and Hep3B from different treatment groups. Here, AKT1 is linked to neoplasm.